Compounds classified as "Designer Drugs" have been synthesized for several decades. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, often exotic names.
Because of many designer drugs are novel or designed to evade detection, they can be overlooked or difficult to detect or characterize. The last decade has seen a proliferation of such substances, such that keeping abreast of this huge number of new drugs is a difficult task for forensic chemists and toxicologists. Compiled by a team originating from the Regional Departments of Criminal Investigation in Kiel, Hamburg, and Wiesbaden, Germany, "Mass Spectra of Designer Drugs" has been developed to help forensics and toxicology labs combat this epidemic.
"Mass Spectra of Designer Drugs 2012 "covers the entire range of designer drugs up to December 2011. Approximately 70% of the compounds covered in the "Designer Drugs" do not appear in either "NIST 2011" or the "Wiley Registry of Mass Spectral Data, 9th Edition."
Specifications:
SpectraMass Spectra: 16,178Compounds: 13,420Structures: 16,178TSQ-spectra: 9,214GCQ-spectra: 1,233CI-spectra: 418HP-spectra: 1,104TRACE-spectra: 1,265GC/MS spectra: 15,991Direct insert mass spectra: 179Number of CAS numbers: 5,248 (32.4%)Number of measured Kovats Indices: 8,607 (53.2%)Number of indication information: 13,131 (81.2%)Number of verified MS:2034 (12.5%)Number of verified MS by independent measurement:3329 (20.6%)Average Peaks/Spectrum: 162.4Average Quality Index/Spectrum: 935.7Replicate Spectra (same interfacing/ionization mode/system): 240
Compound Coverage
Compound coverage for individual compounds can be verified at www.compoundsearch.com Amphetamines: 1125Methylenedioxyphenethylamines: 590Phenethylamines: 1555Tryptamines: 366Piperazines: 887Opiates: 253Fentanyles: 326Cathinones: 432Phencyclidines: 17Tropines: 102Indoles: 244Barbiturates: 75Cannabinoids: 213Cannabimimetics: 165Steroids: 140arylpropan-2-amines: 159arylbutan-2-amines: 413indane-2-amines: 461-aryl-2-nitro-ethenes: 421-aryl-2-nitroprop-1-enes: 651-aryl-2-nitrobut-1-ene: 44Benzaldehydes: 146Designer drug isomers: 899Derivatives: 4533Metabolites incl. derivatives: 3298Chemical warfare agents: 71Designer drug precursors: 725Benzodiazepines: 269Pharmaceutical drugs incl. metabolites: 4254Pesticides: 304Explosives: 45Controlled compounds: 1550
Compatibility
Compatible with most current and legacy mass spectrometry data systems, including: ACD/Labs MS ManagerAgilent Chemstation, MassHunterBruker/VarianJEOLLecoNIST MS SearchPerkinElmer TurboMassShimadzu GCMS SolutionThermoScientific INCOS/GCQ, Spectral ID, XCalibur Waters MassLynx
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
Compounds classified as "Designer Drugs" have been synthesized for several decades. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, often exotic names.
Because of many designer drugs are novel or designed to evade detection, they can be overlooked or difficult to detect or characterize. The last decade has seen a proliferation of such substances, such that keeping abreast of this huge number of new drugs is a difficult task for forensic chemists and toxicologists. Compiled by a team originating from the Regional Departments of Criminal Investigation in Kiel, Hamburg, and Wiesbaden, Germany, "Mass Spectra of Designer Drugs" has been developed to help forensics and toxicology labs combat this epidemic.
"Mass Spectra of Designer Drugs 2012 "covers the entire range of designer drugs up to December 2011. Approximately 70% of the compounds covered in the "Designer Drugs" do not appear in either "NIST 2011" or the "Wiley Registry of Mass Spectral Data, 9th Edition."
Specifications:
SpectraMass Spectra: 16,178Compounds: 13,420Structures: 16,178TSQ-spectra: 9,214GCQ-spectra: 1,233CI-spectra: 418HP-spectra: 1,104TRACE-spectra: 1,265GC/MS spectra: 15,991Direct insert mass spectra: 179Number of CAS numbers: 5,248 (32.4%)Number of measured Kovats Indices: 8,607 (53.2%)Number of indication information: 13,131 (81.2%)Number of verified MS:2034 (12.5%)Number of verified MS by independent measurement:3329 (20.6%)Average Peaks/Spectrum: 162.4Average Quality Index/Spectrum: 935.7Replicate Spectra (same interfacing/ionization mode/system): 240
Compound Coverage
Compound coverage for individual compounds can be verified at www.compoundsearch.com Amphetamines: 1125Methylenedioxyphenethylamines: 590Phenethylamines: 1555Tryptamines: 366Piperazines: 887Opiates: 253Fentanyles: 326Cathinones: 432Phencyclidines: 17Tropines: 102Indoles: 244Barbiturates: 75Cannabinoids: 213Cannabimimetics: 165Steroids: 140arylpropan-2-amines: 159arylbutan-2-amines: 413indane-2-amines: 461-aryl-2-nitro-ethenes: 421-aryl-2-nitroprop-1-enes: 651-aryl-2-nitrobut-1-ene: 44Benzaldehydes: 146Designer drug isomers: 899Derivatives: 4533Metabolites incl. derivatives: 3298Chemical warfare agents: 71Designer drug precursors: 725Benzodiazepines: 269Pharmaceutical drugs incl. metabolites: 4254Pesticides: 304Explosives: 45Controlled compounds: 1550
Compatibility
Compatible with most current and legacy mass spectrometry data systems, including: ACD/Labs MS ManagerAgilent Chemstation, MassHunterBruker/VarianJEOLLecoNIST MS SearchPerkinElmer TurboMassShimadzu GCMS SolutionThermoScientific INCOS/GCQ, Spectral ID, XCalibur Waters MassLynx
Imprint | Wiley-VCH Verlag GmbH |
Country of origin | Germany |
Release date | February 2012 |
Availability | Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available. |
Authors | Peter Rosner |
Dimensions | 140 x 106 x 10mm (L x W x T) |
Format | Digital |
Pages | 350 |
ISBN-13 | 978-3-527-33333-2 |
Barcode | 9783527333332 |
Categories | |
LSN | 3-527-33333-9 |